How to watch the Michigan State vs. Louisville second-round game today in the men's NCAA basketball tournament March Madness ...

Science rarely hands us plot twists this dramatic—where two of the most feared diseases of our time, cancer and Alzheimer’s, ...

The results of the EVOKE and EVOKE+ trials were comprehensive in showing oral semaglutide’s lack of clinical efficacy for ...

Many Black and Latino families are navigating Alzheimer’s without access to the information, resources, and community support ...

HHS Secretary Robert F. Kennedy Jr. appointed Michelle Branham as chair of the federal Advisory Council on Alzheimer’s ...

A new study suggests that two of Alzheimer’s disease’s most debated players may be more closely connected than they first ...

Oral semaglutide (a GLP-1 pill) is not effective at slowing progression in patients with mild Alzheimer's disease, finds the ...

Scientists may have sniffed out a breakthrough when detecting Alzheimer’s. The degenerative disease, which affects millions ...

At AD/PD 2026, one message stood out: when researchers share ideas across Alzheimer’s and Parkinson’s, it could help speed up ...

Two large phase 3 trials found that oral semaglutide 14 mg did not slow cognitive or functional decline over 104 weeks in ...

Could a simple blood test predict your risk of getting dementia years, or even decades, before you experience memory loss?

Amyloid beta and tau proteins compete for the same binding sites on microtubules in neurons, suggesting that displacement of ...